In addition, in this experiment, changes in pulmonary hypertension, FPR2 level in the heart tissue, and effects of FPR2 over-expressing was not delineated, and the sex variation for the in vivo models was also not investigated, and which need further studies. The gene discussed is FPR2; the disease is pulmonary arterial hypertension.